AUS
NZ
UK
CA
USA
IND
_07_03_2026_03_50_21_133108.jpg)
Highlights
- Xencor, Inc. (Nasdaq:XNCR) reported revenue of US$67.4 million in Q2, 2021.
- Healthcare Services Group, Inc (Nasdaq:HCSG) reported a gross profit of US$61.8 million in Q2, 2021.
- Harmony Biosciences Holdings, Inc. (Nasdaq:HRMY) recorded a net income of US$14.12 million in Q2, 2021.
Growth stocks are companies that report higher sales and revenue than the average growth of the sector. These companies generally have a higher P/E ratio, unique products, technology, or patent in their name. Small-cap companies typically have a market cap of US$300 million to US$2 billion.
The healthcare sector comprises companies that produce and sell drugs, provides insurance health cover, or run hospital chains, etc. Here we explore some of the fastest-growing small-cap healthcare companies.
Xencor, Inc. (Nasdaq:XNCR)
The stock of this biopharmaceutical company traded at US$31.96 at 1.53 pm ET on August 17, up 0.63 percent from the August 16 closing price. The stock price of XNCR fell by 26.56 percent YTD. The P/E ratio is 86.58.
The market capitalization of this clinical-stage research company is US$1.8 billion. The forward P/E one year is -42.35. The EPS is US$0.37. The highest and the lowest stock price of XNCR for the past 52 weeks were US$58.54 and US$30.20.
The total revenue of the healthcare company for Q2 this year was US$67.4 million against US$13.1 million of Q2 the previous year. The net income for Q2 this year was US$52.2 million against losses of US$35 million in Q2 the previous year.
Also read: Top mid-cap pharma stocks powering the NASDAQ Biotech Index
Source: Pixabay.
Healthcare Services Group, Inc (Nasdaq:HCSG)
The stock of the healthcare company traded at US$25.97 at 1.59 pm ET on August 17, down 1.81 percent from the August 16 closing price. The stock value of HCSG fell by 7.56 percent YTD. The P/E ratio is 21.57.
The total revenue of HSCG in Q2, 2021, was US$98.2 million against US$452 million in Q2 last year. The gross profit in Q2, 2021, and Q2, 2020, were US$61.8 million and US$64.5 million, respectively. The net income in the latest quarter was US$9.6 million against US$23.1 million in Q2 last year.
The market capitalization of the company is US$1.9 billion. The forward P/E one year is 23.62. The EPS is US$1.20, and the annual dividend is US$0.835. The highest and the lowest stock price of HCSG in the past 52 weeks was US$35.80 and US$20.05.
Harmony Biosciences Holdings, Inc. (Nasdaq:HRMY)
The stock of the pharmaceutical company traded at US$31.77 at 2.18 pm ET on August 17, up 0.83 percent from the August 16 closing price. The stock value of HRMY fell by 12.23 percent YTD. The P/E ratio is 138.04.
The total revenue of the healthcare company in Q2, 2021, was US$73.82 million against US$38.01 million in the year-ago quarter. The gross profit for Q2, 2021, was US$61.13 million against US431.55 million in Q2 last year. The net income for the period was US$14.12 million against losses of US$0.3 million in Q2 the previous year.
The market capitalization of the company is US$1.8 billion. The forward P/E one year is 30.30. The EPS is US$0.23. The highest and the lowest stock price of HRMY for the past 52 weeks was US$52.74 and US$25.09.
Ligand Pharmaceuticals Incorporated (Nasdaq:LGND)
The stock of this biotechnology company traded at US$106.675 at 2.31 pm ET on August 17, down 0.54 percent from the August 16 closing price. The stock value of LGND went up by 9.90 percent YTD. The P/E ratio is 38.6.
The market capitalization of LGND is US$1.7 billion. The forward P/E one year is 24.94. The EPS is US$2.77. The highest and the lowest stock price of LGND in the past 52 weeks was US$219.75 and US$78.26.
The total revenue of the medical research company in Q2, 2021, was US$84.64 million against US$41.42 million in Q2 the previous year. The gross profit for the period was US$54.08 million compared to US$33.78 million in Q2 last year. The net income in Q2 this year was US$30.73 million against US$22.09 million in Q2 last year.
Source: Pixabay.
Avanos Medical, Inc. (NYSE:AVNS)
The stock of the medical equipment company traded at US$33.88 at 2.53 pm ET on August 17, up 0.18 percent from the August 16 closing price. The stock value of AVNS went down by 26.210 percent YTD. The P/E ratio is 1129.67.
The market capitalization of the company is US$1.6 billion. The forward P/E one year is 29.16. The EPS is US$0.03. The highest and the lowest stock price of AVNS for the past 52 weeks was US$53.61 and US$30.92.
Total revenue of the medical technology company in Q2 this year was US$186.4 million against US$163.7 million in Q2 the previous year. The gross profit for the period was US$85.7 million compared to US$86.5 in Q2 last year. The net income in Q2, 2021, was US$37.9 million against US$3 million losses in Q2 the previous year.
Also read: Why are these four pharma stocks drawing investors’ attention?
US Physical Therapy, Inc. (NYSE:USPH)
The stock of the healthcare facilities company traded at US$112.53 at 3.03 pm ET on August 17, up 0.24 percent from the August 16 closing price. The stock value of USPH went down by 6.87 percent YTD. The P/E ratio is 48.25.
The market capitalization of the healthcare services company is US$1.4 billion. The forward P/E one year is 36.10. The EPS is US$2.32, and the annual dividend is US$1.52. The highest and the lowest stock price of USPH for the past 52 weeks was US$143.67 and US$74.79.
The total revenue of the company in Q2 this year was US$126.9 million against US$83.9 million in Q2 the previous year. The gross profit for the period was US$34.3 million compared to US$19.4 in Q2 last year. The net income of the surgical management company in Q2, 2021, was US$12.4 million against US$10.2 million losses in Q2 the previous year.
Bottomline
The coronavirus pandemic proved to be a blessing in disguise for many healthcare companies. The sector is expected to grow further in the coming months as the demand for various health services is also projected to grow.
